This course has expired. View available courses.

Infectious Disease

COVID vaccine in young children – Recommendations for COVID-19 vaccines in children 6 months to 5 years

On July 14, 2022, NACI published guidance on the use of mRNA-1273 in children 6 months to 5 years. This expert brief will review the key recommendations from this guidance and discuss some of the key issues surrounding the discussion of COVID-19 vaccines in young children.

DURATION

25 min

PROFESSION

Physician, Nursing, Pharmacy, Allied Health, Medical Resident, Student, Specialist

# OF CREDITS

0

ACCREDITATION

Unaccredited

EXPIRY DATE

2023-08-23

On July 14, 2022, NACI published guidance on the use of mRNA-1273 in children 6 months to 5 years. This expert brief will review the key recommendations from this guidance and discuss some of the key issues surrounding the discussion of COVID-19 vaccines in young children.


This program has received funding from Moderna.

Faculty

Kristen Watt, BSc, Phm, RPh

Earl Rubin, MDCM

Learning objectives

Upon completion of this continuing education video participants will be better able to:

  • Discuss the current NACI COVID-19 vaccine recommendations for children 6 months to 5 years
  • Describe the effectiveness data of COVID-19 vaccines in young children
  • Explain the potential adverse effects and safety considerations of COVID-19 vaccines in young children
Cost of course:  
Free
# of credits: 0
Duration: 25 min

FAQs & HELP

MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.

All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.

The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

No, registration with MDBriefCase is free!

To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.

If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.

Please note: if you submitted multiple password resets, only the link on the most recent email is valid.

You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.